Gemcitabine, oxaliplatin, 5-FU and folinic acid as an outpatient first-line therapy in patients with inoperable esophageal cancer: A phase I study No significant financial relationships to disclose.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results